Allegra Orthopaedics Limited provided earnings guidance for the full year 2022. For the period, the company's preliminary guidance of its Orthopaedic division, is revenues in the range of $3,200,000 to $3,500,000 and a net loss for the Orthopaedic division in the range of $700,000 to $1,000,000.
Allegra Medical Technologies Limited
Equities
AMT
AU000000AMT8
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.029 AUD | +26.09% | -.--% | -35.56% |
03-22 | Allegra Medical Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
03-11 | Trading in Allegra Medical Technologies' Stock Could Resume on March. 25 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.56% | 2.29M | |
-4.82% | 182B | |
+1.38% | 110B | |
-2.82% | 68.11B | |
+0.69% | 50.53B | |
+8.54% | 44.8B | |
+2.84% | 40.7B | |
+20.50% | 32.25B | |
+1.72% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- AMT Stock
- News Allegra Medical Technologies Limited
- Allegra Orthopaedics Limited Provides Earnings Guidance for the Full Year 2022